| abstract |
It is an object of the present invention to target the expression of alpha interferon for the treatment of cancer, hepatitis, and other conditions that are sensitive to treatment with alpha interferon. An object of the present invention is to provide a recombinant vector for expression of an interferon α polypeptide, the nucleic acid sequence encoding the interferon α polypeptide operably linked to a functional promoter in mammalian cells. This has been solved by providing a vector. [Selection figure] None |